Navigation Links
China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results
Date:11/15/2013

rated $0.8 million in sales in the three months ended September 30, 2013, compared to $1.2 million in the same period of the previous year, a decrease of $0.4 million. 

Gross profit for the three months ended September 30, 2013 was $2.2 million, while gross profit for the three months ended September 30, 2012 was $3.2 million. Our gross profit margin in the third quarter of 2013 was 28%, compared to 27% in the third quarter of 2012. The decrease in gross profit was in line with the performance of revenue in this period, and the gross margin remained stable.

Selling, general and administrative expenses in the third quarter of 2013 were $1.6 million, or 20% of sales, compared to $1.5 million, or 12% of sales, in the third quarter of 2012.  This increase was mainly due to the expenses related to technology upgrades and production process improvements for some of our existing marketed products in the period. For the three months ended September 30, 2013, the Company recognized $3.3 million in bad debt expenses, compared to $0.2 million in the same period of 2012. The increase in bad debt expenses was mainly due to an increase in our accounts receivable that are beyond 720 days old. Our bad debt allowance estimate is currently calculated as the sum of 3.5% of accounts receivable that are less than 360 days old, 10% of accounts receivable that are between 360 days and 720 days old, and 100% of accounts receivable that are greater than 720 days old.

Our operating loss for the three months ended September 30, 2013 was $2.7 million, compared to operating income of $1.6 million in the three months ended September 30, 2012, a decrease of $4.3 million. The main reasons for the decrease were lower revenues and an increase in bad debt expense.

In the three months ended September 30, 2013 and 2012, we paid income tax at the rate of 15%.  The Income tax benefit was $0.5 million in the three months ended September 30, 2013 compared to an i
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. China Jo-Jo Drugstores Announces Fiscal 2014 Second Quarter Financial Results
2. China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call
3. NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement
4. 2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report
5. 2013 Deep Research Report on Global and China Vitamin H Industry
6. 2012 Deep Research Report on Global and China Plastic Injection Molding Machine Industry
7. China Nepstar Chain Drugstore to Report Third Quarter 2013 Financial Results on November 26, 2013
8. China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013
9. Governor-General of Australia Ms. Bryce Visits Sichuan University and Investigates Australia Cochlear Cochlea Project in West China Hospital, Sichuan University
10. The Medical Device Market: China
11. China Biologic Products to Report Third Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Quetiapine ... Developed by AstraZeneca plc, quetiapine (under the ... for the treatment of schizophrenia. Approved by CFDA ... in the Catalogue of Drugs for the Basic ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Ranibizumab ... Developed by Novartis, ranibizumab was approved by CFDA to ... Currently, only Lucentis, a product of Novartis, is available ... the first self- developed drug for the treatment of ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... MYL ) shareholder vote regarding its planned unsolicited offer ... offer to Perrigo shareholders have always been, and will ... of the value available to Perrigo shareholders, and do ... allowed its shareholders to consider," said Joseph C. ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Pharmaceuticals (Nasdaq: ENDP ) announced today the ... President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, an ... products and services based in Austin, Texas. ... Group President James Whittenburg, who is staying through the ...
... Aug. 22, 2011 Leatt Corporation, a Nevada corporation ... Leatt-Brace®, a Neck Brace System designed to help prevent ... (neck), as well as other products, today announced that ... Department of Commerce issued a patent for the Leatt ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3U.S. Patent for Leatt Neck Brace System Issued 2
(Date:8/28/2015)... ... 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, a ... carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that ... Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected by ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs ... Dr. James Strawbridge, gives a new approach on solutions in his new book ... the employer and employees getting together for meaningful group meetings. "This would educate ...
(Date:8/28/2015)... Utah (PRWEB) , ... August 28, 2015 , ... ... awarded a three-year accreditation for its adolescent residential, counseling, day treatment and intensive ... that it meets international standards for quality and its pursuit of excellence. As ...
(Date:8/28/2015)... ... 2015 , ... The Quatela Center for Plastic Surgery is excited to bring ... product approved by the Food and Drug Administration to eliminate submental fat, also known ... Koenig are among the premier cosmetic surgeons in Rochester to offer this innovative ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil the ... revolutionary Thermal Flavor Extraction™ technology, which delivers a variety of sizes and styles ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... ... team at The Balancing Act discovered that killing nasty germs has just become ... we run around with a can of disinfectant spraying everything is sight. ... Balancing Act, along with special guest Dr. Bob Arnot Thursday, May 27th at ...
... New CR Series ... instrument, makes immune monitoring much faster and simpler. , ... (PRWEB) May 23, 2010 -- Blue Ocean Biomedical introduced ... Society for Advancement of Cytometry (ISAC), called CYTO 2010, held in Seattle, Washington from ...
... , ... celebrates the rebranding of their website. The family-owned company operates CGadget.com that supplies ... ... 22, 2010 -- PGS Plus celebrates the rebranding of their website. The family-owned ...
... ... ... May 22, 2010 -- Graham Gibson is giving back to the community ... and beauty products, Gibson gives these items to local organizations who are interested in ...
... ... intolerance and celiac disease , ... Burlingame, CA (PRWEB) May 22, 2010 -- LoveToKnow, Inc. has launched a new Web site ... disease. In addition, as part of a campaign to help people with these issues, the ...
... ... ... edition of The Balancing Act, we are bringing viewers some vitally important information about managing the ... a plan that can help make sure that your family is covered. , , , ...
Cached Medicine News:Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes Dr. Bob Arnot to the Program 2Health News:New Blue Ocean Load & Go™ CR Series Immune Monitoring Systems Debut at ISAC CYTO 2010 2Health News:New Blue Ocean Load & Go™ CR Series Immune Monitoring Systems Debut at ISAC CYTO 2010 3Health News:New Blue Ocean Load & Go™ CR Series Immune Monitoring Systems Debut at ISAC CYTO 2010 4Health News:CGadget.com Launches a New Look for Summer 2010 2Health News:Local Businessman Gives Back To the Community 2Health News:LoveToKnow.com Launches Gluten Free Channel and Will Donate to National Foundation for Celiac Awareness 2Health News:LoveToKnow.com Launches Gluten Free Channel and Will Donate to National Foundation for Celiac Awareness 3Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes HSA Bank to the Program 2
... Carl Zeiss has successfully advanced into the ... success of this instrument is by no ... and stylish design. Maximum ergonomic convenience is ... be used with a surgical microscope, allowing ...
Leg holder for arthroscopy....
... Featuring two rapid response roller-pumps, ... maintaining a clear surgical field. Furthermore ... surgeon total control over intra-articular pressure ... system includes foot pedal controls, providing ...
Designed to address the specific demands of the busy operating environment, the AL1 Light Source features state-of-the art 180W Xenon lamp technology, providing light output suitable for all endoscop...
Medicine Products: